City
Epaper

Quantum computing, AI to revolutionise drug discovery in India: Ex-ICMR chief

By IANS | Updated: February 20, 2025 16:35 IST

New Delhi, Feb 20 Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable ...

Open in App

New Delhi, Feb 20 Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable the country to become a global hub for pharmaceutical advancements, said Dr. Balram Bhargava, Former Director General, ICMR.

He was speaking at the 9th "International Symposium on Current Trends in Drug Discovery Research” at CSIR-Central Drug Research Institute, Lucknow.

“India's strength in drug discovery stems from its rich heritage in chemistry, making it a global hub for pharmaceutical advancements,” said Bhargava, Dean and Senior Consultant, Holy Family Hospital, New Delhi.

“The integration of Quantum Computing and Artificial Intelligence (AI) is set to revolutionise drug discovery, accelerating research and reducing costs,” he added.

The expert noted that India has consistently demonstrated its ability to produce high-quality, affordable medicines, ensuring healthcare accessibility worldwide. However, challenges such as the availability of Active Pharmaceutical Ingredients (APIs) and the need for new drug discoveries remain key areas of focus.

Further, Bhargava called for collaborations to boost India's pharmaceutical success, as seen in the development of vaccines.

“Market shaping is equally important, ensuring that innovations reach the masses while maintaining India's leadership in cost-effective healthcare solutions,” he said.

The event, aimed to discuss new strategies in synthetic and medicinal chemistry in the country, also witnessed the presence of global experts from the universities of Florida and Minnesota in the US. They spoke on breakthroughs in pain management strategies as well as the need to develop new antimicrobial agents with novel mechanisms.

Meanwhile, Dr. Arindam Talukdar from CSIR-Indian Institute of Chemical Biology (IICB), Kolkata, shared his research findings on the stimulation of agonism-antagonism in TLR7 modulators via complex interactions between chemical subunits.

The TLR7 is an endosomal TLR protein that helps the body to recognise and respond to viruses and bacteria.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentWhen Amit Kumar spoke about Kishore Kumar’s penchant for vengeance

EntertainmentDhanashree Verma’s reaction goes viral amid Samay Raina’s “sugar daddy” caption for Yuzvendra Chahal

NationalPM Modi pays tribute to Tamil freedom icons Tiruppur Kumaran, Subramania Siva

NationalChugh hails PM Modi for allowing Nankana Sahib jatha to Pakistan

NationalHaryana CM urges traders to pass on benefit of reduced GST rates to consumers

Health Realted Stories

HealthHealth industry bodies welcome CGHS’ move to revise rates after 15 years

HealthRajasthan cough syrup deaths: All 19 medicines of pharma firm suspended, 3 officials removed

HealthMultidisciplinary team probing to assess cause of cough syrup deaths in MP, Rajasthan: Govt

HealthTN cough syrup samples adulterated; production halted after child deaths in MP, Rajasthan

HealthMP orders blanket ban on toxic 'Coldrif' syrup sale, all quantities to be disposed immediately